4Front Ventures Corp.

Equities

FFNT

CA35086B2075

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange Other stock markets 11:14:18 2024-04-25 am EDT			5-day change	1st Jan Change
0.125 ^CAD	0.00%		-10.71%	-3.85%

Apr. 15	Transcript : 4Front Ventures Corp., Q4 2023 Earnings Call, Apr 15, 2024
Apr. 15	4Front Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

4Front Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2021

March 31, 2022 at 06:14 am EDT

4Front Ventures Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 11.18 million compared to USD 11.02 million a year ago.

Revenue was USD 104.57 million compared to USD 57.64 million a year ago. Net loss was USD 34.91 million compared to USD 47.05 million a year ago. Basic loss per share was USD 0.06 compared to USD 0.09 a year ago.

Latest news about 4Front Ventures Corp.

Transcript : 4Front Ventures Corp., Q4 2023 Earnings Call, Apr 15, 2024	Apr. 15
4Front Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
4Front Ventures Corp. Provides Progress Report on Norridge Opening and Matteson Facility Updates	Mar. 21	CI
4Front Ventures Corp. Expands its Vape Product Portfolio with the Introduction of Crystal Clear Blast in Massachusetts and Illinois	Mar. 21	CI
4Front Ventures Unveils Mission: A Signature Cannabis Experience	Feb. 20	CI
4Front Ventures Corp. Furthers Expansion Strategy in Illinois Activates Power at 250,000 Sq Ft Facility in Matteson	Feb. 05	CI
4Front Ventures Corp. Announces Chief Executive Officer Changes	Jan. 08	CI
4Front Ventures Corp. Debuts Cannabis Flower Brand the Hunt	Dec. 11	CI
4Front Ventures Corp. Announces Chief Financial Officer Changes	Nov. 29	CI
Transcript : 4Front Ventures Corp., Q3 2023 Earnings Call, Nov 20, 2023	Nov. 20
Earnings Flash (FFNTF) 4FRONT VENTURES Reports Q3 Revenue $23M	Nov. 20	MT
4Front Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
4Front Ventures Secured US$10 Million Credit Facility	23-10-16	MT
4Front Ventures Corp. Secures $10 Million Credit Facility	23-10-16	CI
4Front Ventures Corp. announced that it expects to receive $10 million in funding	23-10-15	CI
4Front Ventures Broadens Illinois Offerings with Expansion of Island Cannabis Co. Product Line	23-09-14	CI
Transcript : 4Front Ventures Corp., Q2 2023 Earnings Call, Aug 15, 2023	23-08-15
4Front Ventures Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
4Front Ventures Corp. Announces Update to Senior Management Team	23-08-04	CI
Amit Patel Steps Down as a Director of 4Front Ventures Corp	23-05-22	CI
Transcript : 4Front Ventures Corp., Q1 2023 Earnings Call, May 15, 2023	23-05-15
4Front Ventures Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
4Front Ventures Brief: Systemwide Pro Forma Revenue of US$34.8 million in Q1 2023	23-05-15	MT
4Front Ventures Corp. entered into a Membership Interest Purchase Agreement to acquire Euphoria, LLC for $4.5 million.	23-05-14	CI
4Front Ventures Corp. Announces Non-Binding Term Sheet for Extension of Senior Secured Debt	23-05-09	CI

Chart 4Front Ventures Corp.

Duration

Period

More charts

Company Profile

4Front Ventures Corp. is a multi-state cannabis operator and retailer. The Company owns or manages licensed cannabis facilities in state-licensed markets in the United States. It manufactures and distributes a portfolio of over 25 cannabis brands including Marmas, Crystal Clear, Island, Verdure, and the Pure Ratios wellness collection, which is distributed through retail outlets, as well as the Companyâs chain of branded dispensaries. The Company's segments include THC Cannabis and CBD Wellness. The THC Cannabis segment is engaged in cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third-party retailers, ancillary services supporting wholesale operations, and retail sales direct to end consumers. It also leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington. The Companyâs CBD Wellness segment sells non-THC hemp derived products across the United States.

Sector

Healthcare Facilities & Services

Calendar

2024-05-19 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

0.125 CAD

Average target price

0.125 CAD

Spread / Average Target

0.00%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
4FRONT VENTURES CORP.	-3.85%	83.42M
ASCEND WELLNESS HOLDINGS, INC.	+27.84%	264M
AYR WELLNESS INC.	+28.81%	251M
ORGANIGRAM HOLDINGS INC.	+48.84%	193M
JUSHI HOLDINGS INC.	+38.04%	125M
THE CANNABIST COMPANY HOLDINGS INC.	-41.00%	122M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
INTERCURE LTD.	+115.91%	120M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M
GOLD FLORA CORPORATION	+12.50%	51.77M

Medical Farming